Delaware

  • September 17, 2004

    AstraZeneca Sues KV Pharma Over ANDA For Toprol-XL Generic

    U.K-Swedish drug maker AstraZeneca has sued generic maker KV Pharmaceutical Company for patent infringement over its plans to launch a 50 mg generic version of hypertension drug Toprol-XL.

  • September 15, 2004

    U.K. Technology Company Sues Amazon, Others Over Web Tracking Technology

    British Technology Group (BTG), a London-based company involved in intellectual property and technology commercialization, has filed a lawsuit against Amazon.com, Barnesandnoble.com, and two other internet companies that it accuses of infringing on patents related to the tracking of internet users.

  • September 14, 2004

    Proxim Pays $23M To Settle Symbol's WLAN Patent Suit

    Wireless gear maker Proxim has agreed to pay rival Symbol Technologies $23 million to settle a protracted patent lawsuit.

  • September 8, 2004

    Applera Sues Thermo Electron Over Mass Spectrometer Patent

    Medical device maker Applera and its subsidiary Applied Biosystems/ MDS Scientific Instruments have sued rival Thermo Electron Corporation for patent infringement in a dispute over mass spectrometer systems.

  • September 8, 2004

    Novo Nordisk To Appeal Decision On Norditropin

    Danish drug maker Novo Nordisk has decided to appeal a court decision that rendered its patent for recombinant human growth hormone invalid and unenforceable due to inequitable conduct at the U.S. Patent and Trademark Office.

  • September 7, 2004

    Sony, Adobe, Macromedia Reported To Settle Forgent Suit Over JPEG Patent

    Several major software and high-tech companies, including Sony, Adobe and Macromedia, have settled a controversial lawsuit brought by Austin company Forgent Networks Inc., over the compression, storage, manipulation and transmission of still digital images in JPEG format, according to a published report.

  • September 3, 2004

    Pfizer Sues 18 Online Vendors of "Generic" Lipitor

    U.S. drug maker Pfizer Inc. has launched a second round of lawsuits against online vendors of Lipitor, targeting eighteen internet sites that claim to sell generic versions of the blockbuster anti-cholesterol drug.

  • September 2, 2004

    Impax Loses Bid For Generic Version Of Rilutek

    Impax Laboratories Inc.'s proposed generic version of Rilutek infringes on Aventis SA's patent for the brand version of the drug, a U.S. federal court has ruled.

  • August 25, 2004

    Allergan Sues Alcon Over Alphagan Patent

    Allergan, Inc. has sued Alcon, Inc. for patent infringement over its plans to make a generic version of its Alphagan eye drops.

  • August 26, 2004

    Canon Buys Candescent's Flat-Panel Patent Portfolio

    In a sign of the rising value of intellectual property in the fast-growing market for flat-panel displays, Canon Inc. has agreed to pay 1.3 billion yen ($11.8 million) for Candescent Technologies’ patent portfolio, according to news reports.

  • August 24, 2004

    Benitec Settles Suit Vs. Genscript Over RNAi Patent

    Australian biotech company Benitec Ltd. has settled its U.S. patent infringement case against rival Genscript over gene silencing technologies, just two weeks after it settled its suit against Ambion under similar terms.

  • August 23, 2004

    Teva Loses Patent Challenge For Glaxo's Zofran

    A federal judge has upheld the validity of two key method-of-use patents for GlaxoSmithKline’s anti-nausea drug Zofran (ondansetron), dealing a blow to challenger Teva Pharmaceuticals.

  • August 23, 2004

    Genesis Wins ITC Complaint Vs. Taiwanese Rivals Over LCD Controller Patent

    Taiwanese chip makers MStar Semiconductor, Media Reality Technologies (MRT) and Trumpion Microelectronics infringed a patent for liquid crystal display (LCD) controllers held by rival Genesis Microchip, the U.S. International Trade Commission said in a final determination.

  • August 20, 2004

    Illumina and Applera Settle Patent Disputes

    Biotech rivals Illumina, Inc. and Applera Corp. have agreed to settle two lawsuits over a partnership that went sour, penning a deal that involves royalty-free cross-licensing of key technologies and the dismissal of a patent infringement suit.

  • August 19, 2004

    Cornice Countersues Seagate In Patent Fight Over Disk-Drive Technology

    Disk-drive maker Cornice has fired a legal volley back at one of the companies that sued it for patent infringement earlier this year, filing a countersuit against rival Seagate Technology over its patent rights for tiny disk drives.

  • August 19, 2004

    Federal Circuit Affirms District Court's Ruling For Fisher-Price Vs. Safety 1st

    The U.S. Court of Appeals for the Federal Circuit has affirmed a district court jury's finding that Dorel Industries’ Safety 1st unit infringed two patents held by toymaker Mattel Inc.’s Fisher-Price unit, and said another product should be considered when a new jury calculates damages.

  • August 17, 2004

    Qualcomm Abandons Bid For Damages In Licensing Spat With TI

    In a move designed to protect its licensing agreements with other companies, Qualcomm has abandoned its bid for at least $18 million damages from Texas Instruments in its lawsuit over TI’s alleged breach of a licensing deal for CDMA technology.

  • August 15, 2004

    Trading Technologies Sues eSpeed Over Bond Trading Technology

    Patent litigation is on the rise in the lucrative market for bond trading technology, with several players suing each other as they jostle for control over the electronic systems that support the $3.3 trillion bond market.

  • August 12, 2004

    ITC Probes Sony Over Digital Camera Patent

    The U.S. International Trade Commission has launched an investigation into whether Sony Corp.'s digital cameras and cellular phones with digital image capabilities are infringing a patent held by California-based Ampex Corp., the ITC said Wednesday.

  • August 10, 2004

    Benitec Settles Patent Dispute With Ambion

    Australian biotech company Benitec Ltd. has settled its U.S. patent infringement case against rival Ambion over gene silencing technologies.